Found: 35
Select item for more details and to access through your institution.
Assessing software upgrades, plan properties and patient geometry using intensity modulated radiation therapy (IMRT) complexity metrics.
- Published in:
- Medical Physics, 2011, v. 38, n. 4, p. 2027, doi. 10.1118/1.3562897
- By:
- Publication type:
- Article
What is the role of the bystander response in radionuclide therapies?
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00215
- By:
- Publication type:
- Article
Establishing metastatic prostate cancer quality indicators using a modified Delphi approach.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 2, p. e151, doi. 10.1016/j.clgc.2021.11.018
- By:
- Publication type:
- Article
Feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor (EXACT)
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 7, p. 1, doi. 10.1007/s00520-023-07894-1
- By:
- Publication type:
- Article
Modulating Tumour Hypoxia in Prostate Cancer Through Exercise: The Impact of Redox Signalling on Radiosensitivity.
- Published in:
- Sports Medicine - Open, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40798-022-00436-9
- By:
- Publication type:
- Article
Use of bisphosphonates and other bone supportive agents in the management of prostate cancer-A UK perspective.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Radium-223 Dichloride (Ra-223) for the Treatment of Metastatic Castration-resistant Prostate Cancer: Optimizing Clinical Practice in Nuclear Medicine Centers.
- Published in:
- Journal of OncoPathology, 2015, v. 3, n. 1, p. 1, doi. 10.13032/tjop.2052-5931.100121
- By:
- Publication type:
- Article
Vasoactivity of Rucaparib, a PARP-1 Inhibitor, is a Complex Process that Involves Myosin Light Chain Kinase, P2 Receptors, and PARP Itself.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0118187
- By:
- Publication type:
- Article
Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for <i>BRAF</i>, <i>EGFR</i> and <i>KRAS</i> Mutational Analysis.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069604
- By:
- Publication type:
- Article
A Kinetic-Based Model of Radiation-Induced Intercellular Signalling.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0054526
- By:
- Publication type:
- Article
DNA Damage Responses following Exposure to Modulated Radiation Fields.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0043326
- By:
- Publication type:
- Article
Prostate cancer treated with brachytherapy; an exploratory study of dose-dependent biomarkers and quality of life.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Active surveillance for favorable-risk prostate cancer: Is there a greater psychological impact than previously thought? A systematic, mixed studies literature review.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Synergistic Activity of DNA Damage Response Inhibitors in Combination with Radium-223 in Prostate Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1510, doi. 10.3390/cancers16081510
- By:
- Publication type:
- Article
Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles.
- Published in:
- International Journal of Nanomedicine, 2012, v. 7, p. 2673, doi. 10.2147/IJN.S31751
- By:
- Publication type:
- Article
Optimising the use of the prostate- specific antigen blood test in asymptomatic men for early prostate cancer detection in primary care: report from a UK clinical consensus.
- Published in:
- British Journal of General Practice, 2024, v. 74, n. 745, p. e534
- By:
- Publication type:
- Article
A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for [sup 186]Re-HEDP treatment of skeletal metastases from prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 8, p. 1114, doi. 10.1007/s00259-003-1197-y
- By:
- Publication type:
- Article
Inverse planned constant dose rate volumetric modulated arc therapy (VMAT) as an efficient alternative to five-field intensity modulated radiation therapy (IMRT) for prostate.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Modulating the unfolded protein response with ONC201 to impact on radiation response in prostate cancer cells.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-83215-y
- By:
- Publication type:
- Article
Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial ( ISRCTN 12808747).
- Published in:
- BJU International, 2017, v. 119, n. 4, p. 522, doi. 10.1111/bju.13549
- By:
- Publication type:
- Article
Debating controversies in the management of locally advanced prostate cancer.
- Published in:
- Trends in Urology & Men's Health, 2011, v. 2, n. 3, p. 38, doi. 10.1002/tre.203
- By:
- Publication type:
- Article
A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy.
- Published in:
- Trials, 2010, v. 11, p. 86, doi. 10.1186/1745-6215-11-86
- By:
- Publication type:
- Article
Time and Cell Type Dependency of Survival Responses in Co-cultured Tumor and Fibroblast Cells after Exposure to Modulated Radiation Fields.
- Published in:
- Radiation Research, 2015, v. 183, n. 6, p. 656, doi. 10.1667/RR13992.1
- By:
- Publication type:
- Article
A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 10, p. 2641, doi. 10.1002/cncr.26544
- By:
- Publication type:
- Article
Differential responses to <sup>223</sup>Ra and Alpha-particles exposure in prostate cancer driven by mitotic catastrophe.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.877302
- By:
- Publication type:
- Article
StereoTactic radiotherapy for wet Age- Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial.
- Published in:
- Trials, 2016, v. 17, p. 1, doi. 10.1186/s13063-016-1676-7
- By:
- Publication type:
- Article
StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Reply to 'Single high dose versus repeated bone-targeted radionuclide therapy'.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Radiation-induced bystander signalling in cancer therapy.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Exercise for advanced prostate cancer: a multicomponent, feasibility, trial protocol for men with metastatic castrate-resistant prostate cancer (EXACT).
- Published in:
- Pilot & Feasibility Studies, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1186/s40814-019-0486-6
- By:
- Publication type:
- Article